A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...

One of the world’s biggest drug makers is suing the country’s smallest state. The argument is over a federal drug discount program ...

The dramatic growth of a key federal drug discount program has fueled debate about whether it is helping low-income patients as intended or primarily benefiting health care providers.

Several recent policy proposals are placing new pressures on the 340B drug pricing program, a decades-old federal initiative many hospitals and health systems depend on to offset the costs of care for ...

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many questioning whether those savings are being used ...

In victory for struggling medical providers, law protecting a federal drug discount program in RI goes into effect despite ...

The 340B program, enacted by Congress in 1992, requires pharmaceutical companies to sell medications to rural hospitals at ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

Amid ongoing controversy over 340B drug discounts, a sweeping review suggests the program is doing what it was intended to do: generate revenue for hospitals, clinics and pharmacies by requiring ...

On Wednesday, health care providers and drug manufacturers hotly debated legislation looking to ensure hospitals can purchase ...

The heavily scrutinized 340B Drug Pricing Program is back in the spotlight as the Trump administration targets drug costs in a recent Executive Order. The 340B Drug Pricing Program has received a lot ...

The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...